Anita Pramoda Biography and Net Worth

Director of GoHealth

Anita Pramoda has served as a member of GoHealth, Inc.’s board of directors since 2020. Anita is CEO of Owned Outcomes, a software company that enables data-driven decision making for healthcare providers and payors as they seek financial sustainability alongside clinical outcomes in value-based patient care. From 2009 to 2012, Ms. Pramoda was the CFO at Epic Systems Corporation, a leading healthcare IT company which provides EMR solutions. Prior to Epic, Anita helped commercialize self-healing packaging technology in the wholesale, retail, and military sectors at Ontech. Earlier in her career, Anita worked with tech and healthcare companies in a variety of technology, strategic advisory, and financing roles at UBS. She also served global healthcare and life sciences clients at Arthur Andersen. Ms. Pramoda currently serves on the board of the Federal Reserve of San Francisco and Health Catalyst. Ms. Pramoda holds an MBA from the Wharton School at the University of Pennsylvania.

What is Anita Pramoda's net worth?: The estimated net worth of Anita Pramoda is at least $54,543.58 as of June 15th, 2021. Ms. Pramoda owns 4,186 shares of GoHealth stock worth more than $54,544 as of November 5th. This net worth approximation does not reflect any other investments that Ms. Pramoda may own. Learn More about Anita Pramoda's net worth.
How do I contact Anita Pramoda?: The corporate mailing address for Ms. Pramoda and other GoHealth executives is 214 WEST HURON STREET, CHICAGO IL, 60654. GoHealth can also be reached via phone at 312-386-8200 and via email at [email protected]. Learn More on Anita Pramoda's contact information.
Has Anita Pramoda been buying or selling shares of GoHealth?: Anita Pramoda has not been actively trading shares of GoHealth during the last ninety days. Most recently, on Friday, March 12th, Anita Pramoda bought 10,370 shares of GoHealth stock. The stock was acquired at an average cost of $9.99 per share, with a total value of $103,596.30. Following the completion of the transaction, the director now directly owns 22,275 shares of the company's stock, valued at $222,527.25. Learn More on Anita Pramoda's trading history.
Who are GoHealth's active insiders?: GoHealth's insider roster includes Brandon Cruz (Insider), Shane Cruz (COO), Clinton Jones (CEO), and Anita Pramoda (Director). Learn More on GoHealth's active insiders.
Are insiders buying or selling shares of GoHealth?: In the last twelve months, GoHealth insiders bought shares 1 times. They purchased a total of 7,500 shares worth more than $100,275.00. The most recent insider tranaction occured on November, 13th when CEO Vijay Kotte bought 7,500 shares worth more than $100,275.00. Insiders at GoHealth own 35.0% of the company. Learn More about insider trades at GoHealth.
Information on this page was last updated on 11/13/2023.

Anita Pramoda Insider Trading History at GoHealth

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
3/12/2021	Buy	10,370	$9.99	$103,596.30	22,275

Anita Pramoda Buying and Selling Activity at GoHealth

GoHealth Company Overview

GoHealth, Inc. operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs. It provides Medicare plans, including Medicare Advantage, Medicare Supplement and Prescription Drug, and Medicare Special Needs Plans. The company also offers partner marketing services. It sells its products through carriers and online platform, as well as independent and external agencies. The company was founded in 2001 and is headquartered in Chicago, Illinois.

Today's Range

Now: $13.03

$12.65

$13.40

50 Day Range

MA: $9.55

$7.59

$12.65

2 Week Range

Now: $13.03

$7.27

$16.44

Volume

6,195 shs

Average Volume

17,828 shs

Market Capitalization

$297.61 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.66

NASDAQ small cap that could be gearing up for a massive short squeeze.

From Huge Alerts | Ad

A Heavy Short Interest Could Lead to a Monstrous Short Squeeze for this Tiny NASDAQ Healthcare Firm!

See how this NASDAQ Bio-tech is offering viable solutions